Corporate Profile

Terumo (TSE:4543) is a global leader in medical technology and has been committed to "Contributing to Society through Healthcare" for nearly 100 years. Based in Tokyo and operating globally, Terumo employs more than 26,000 associates worldwide to provide innovative medical solutions in more than 160 countries and regions. The company started as a Japanese thermometer manufacturer, and has been supporting healthcare ever since. Now, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice. Terumo will further strive to be of value to patients, medical professionals, and society at large.

Company Name Terumo Corporation
Head Office 2-44-1 Hatagaya, Shibuya-ku, Tokyo, 151-0072 Japan
Tel. +81-3-3374-8111
Date of Establishment September 17, 1921
Corporate Stock First section of the Tokyo Stock Exchange
(Code: 4543)
Capital Stock 38.7 billion yen
Revenue 628.9 billion yen (for FYE Mar. 2020)
Representative Directors Takayoshi Mimura, Chairman of the Board
Shinjiro Sato, President and CEO
Number of Employees 26,438 (Consolidated)
Main Business Manufacture and sales of medical products and equipment, including pharmaceuticals, nutritional food supplement, blood bags, disposable medical devices, cardiovascular systems, vascular grafts, peritoneal dialysis, blood glucose monitoring system, medical electronic, and digital thermometers.
Global Network
T
O
P